BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. - Test2 - elhamkhani - TriplyDB

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

http://www.wikidata.org/entity/Q34560988

about

B-Raf and the inhibitors: from bench to bedside Targeting BRAF in thyroid cancer Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends Selective use of sorafenib in the treatment of thyroid cancer Robotic transaxillary and retroauricular parathyroid surgery Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions Progress in molecular-based management of differentiated thyroid cancer Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.Highly prevalent TERT promoter mutations in aggressive thyroid cancers.BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer Oxidative stress: a new risk factor for thyroid cancer BRAF mutations in advanced cancers: clinical characteristics and outcomes 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies.Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.The role of podoplanin in the biology of differentiated thyroid cancers.Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma.A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma Senescent tumor cells lead the collective invasion in thyroid cancer.Personalized medicine: the future is not what it used to be.Thyroid cancer: current molecular perspectives.Prognostic utility of BRAF mutation in papillary thyroid cancer.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.Application of molecular diagnostics to the evaluation of the surgical approach to thyroid cancer Occult thyroid carcinoma Evaluation of a thyroid nodule.Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer Multi-targeted approach in the treatment of thyroid cancer.PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells Old and new insights in the treatment of thyroid carcinoma.

P2860

Q21198860-EFFB3757-CD14-4F7E-86A2-72906937C2F1 Q24653496-82E58627-726E-496B-A6F1-D13F05027B4D Q26749311-9149C740-A170-4C71-8C5C-CCB36A95813F Q26752891-DA9416D7-F3A5-47AC-A9DA-1DBA1DFD437A Q26783249-CDCEB08F-E31B-4F7D-9800-3B73822A2544 Q26853261-4AF3698E-110A-4BB8-98CF-6212C5602214 Q26863326-1E03ED90-F333-4713-8495-6578269DF5AB Q26999887-B7956585-09B1-45EF-80A4-DBD566CD0E4C Q27851648-47FB794C-9758-4D0E-8285-AE512B29A66C Q27852353-F93A5CD3-AAD7-40B8-B29A-F5A5FD5BC11C Q27853042-1373A304-7A7D-4D3B-B7D0-71DF563D05B8 Q27853057-4F49EEE2-5CFF-4856-9E84-B7A508C8FE95 Q27853396-57D88A0F-D498-4573-A473-7157994538CE Q28253304-C25D3D3F-93D5-4912-9B66-2055B4FA0841 Q28388902-3B25C26E-A889-4B40-BBD1-33592F0076C6 Q28743591-6F026E71-947D-4077-980A-DB47EBF73884 Q30367068-C9751B1A-B8CE-4FA8-967A-58212A0C3395 Q30458424-38D4A86B-1403-41D2-945E-3FF4F47E5A56 Q31114420-42761C0F-DBE7-41B7-A4B5-F6C7179C73F2 Q33480990-F6C0E0B5-233E-4CA5-8DB9-C1F5B1DABC18 Q33568168-A746F7C0-412F-4957-ACB9-511147AB139E Q33597740-C0EA61C5-F95C-4EFD-85C9-C7C5422E1793 Q33656624-7F8C3DCA-02B8-41A1-BC3B-B2A9CDBE5A82 Q33702243-FCF176A7-7226-49EB-857C-5C18C5BA99DF Q33750281-80FE1AE3-F6B0-4A2A-AED1-F2887C05DA4F Q33760910-07BBAFB6-A0FA-4972-8737-176A4B092D08 Q33771120-9A0BA933-9549-4DB2-A84F-3E5D321F4C92 Q33782114-89CA2B07-D55B-452A-B0D2-2ADDD8F987E4 Q33782121-D8BA98DF-AA2A-4495-A8AF-7A08292AE23B Q33844111-3A56664A-F986-46E6-B569-FFE22A85E9C6 Q33888762-4AD363E9-FA77-435A-8169-C7667DF0A407 Q33909942-DCBB7F1E-CAF4-4864-859B-D5FAA5E5B595 Q33982413-01AB1F00-D599-435F-8CDD-B1F149BD5261 Q33987852-DE9A6D72-FBC4-4132-AC5B-A5973E4B7761 Q34018753-CB5DCEC8-837D-4FE8-BC10-71904EC362B0 Q34041618-C999FF2F-539B-409E-AF15-EA826DF16350 Q34119098-2E2CF1A1-6092-4AE5-9671-5311F34D752D Q34123724-EE388A45-E049-4030-AD8B-65E02C201655 Q34123904-0BE2C0D2-B786-497E-B18C-37F300FFDA44 Q34209934-5636ED3A-7E1E-41A2-8D05-ABE51AA241A1

P2860

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

http://www.wikidata.org/entity/Q34560988

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@ast

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@en

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@nl

type

label

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@ast

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@en

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@nl

prefLabel

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@ast

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@en

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@nl

P1433

Q34560988-EFA7AE77-3C92-4036-9061-7C225FC31734

P1476

Q34560988-726C9090-93D6-4A74-AE19-E53B165EE005

P2093

Q34560988-0EF286BF-8FA6-4782-A3E7-7142F382C60D

Q34560988-17E3493A-C2CE-4585-9BCB-71329A6CD2C4

Q34560988-1FADDAA3-18B5-4B03-8493-EA0045EDA17C

Q34560988-2AE94F94-5348-4B1C-8BE7-DE9A4ED142F9

Q34560988-4989F07F-53F0-4AF9-929B-925BFA347E7A

Q34560988-4D351892-BE45-4648-B3C3-F464536D488C

Q34560988-4DB556A2-D7C8-47A6-9F86-B17C36A185DD

Q34560988-58B12871-CF01-4155-9A63-442EC71578D5

Q34560988-5FB15749-286A-4669-B50F-F0323A48FEF3

Q34560988-87788861-52C7-4D91-BD34-41D998F6ED19

P304

Q34560988-A9C6C49F-57FC-4810-942C-8FA2AC0E90D8

P31

Q34560988-E02CD21F-EE22-453F-980D-DDB912B02DA7

P356

Q34560988-430CCFB1-9EF5-4CD9-8261-4D4059089E1B

P407

Q34560988-ADC8B59F-6C27-447E-B9DB-04E0C92BB1D8

P433

Q34560988-FDEA9FD1-FD7C-4666-BF68-53FD1F26F68F

P478

Q34560988-2B3AFA8D-B30C-426C-A2C8-98151A1DB2B2

P577

Q34560988-6901F3FF-BCA0-4F16-BE96-836C93CCB102

P5875

Q34560988-B7806F65-EBB5-4C22-A193-DF0A5107A7E9

P698

Q34560988-D675667B-6D00-4686-B298-9EF0156CC40E

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

@en

P2093

Alexandr Larin

http://www.w3.org/2001/XMLSchema#string

Anthony P Tufaro

http://www.w3.org/2001/XMLSchema#string

Christopher B Umbricht

http://www.w3.org/2001/XMLSchema#string

David Sidransky

http://www.w3.org/2001/XMLSchema#string

Eli Rosenbaum

http://www.w3.org/2001/XMLSchema#string

Elizabeth H Holt

http://www.w3.org/2001/XMLSchema#string

Giovanni Tallini

http://www.w3.org/2001/XMLSchema#string

Joseph A Califano

http://www.w3.org/2001/XMLSchema#string

Kathryn A Carson

http://www.w3.org/2001/XMLSchema#string

Kerry J Rhoden

http://www.w3.org/2001/XMLSchema#string

P304

6373-6379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2005-0987

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7588641

http://www.w3.org/2001/XMLSchema#string

P698

16174717

http://www.w3.org/2001/XMLSchema#string